AI-generated summary
This Cochrane review pooled 20 randomized trials comparing bright light therapy with inactive placebo for non-seasonal depression. The authors report a non-significant overall benefit, with better responses in high-quality studies and morning light treatment, and more hypomania in the bright light group. They caution that the data are limited and heterogeneous.
- Studies included
- 20
- Who or what was studied
- Adults with non-seasonal depression
- Limits stated in the abstract
- The authors state that data were limited, studies were heterogeneous, reporting quality was generally poor, and results should be interpreted with caution.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Statistical significance, Confidence interval, Heterogeneity, Phototherapy, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.